ESR1 and inflammatory breast carcinoma: Several characteristics of PIK3CA mutations and expression in IBC have been observed, including a strong association with the estrogen receptor, a lack of an association with robust activation of the classical PI3K pathway, as well as a relatively better prognosis for patients with mutation type compared with wild-type counterparts 9-17.